Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07444463

Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical Applications

Previous and our studies have shown that cognitive impairments are core symptoms of three major psychiatric disorders-schizophrenia, bipolar disorder, and major depressive disorder, and are associated with underlying brain dysfunction. However, the specific brain networks involved in cognitive impairments (cognitive impairment brain networks) in these disorders, as well as whether their neuroimaging features can be applied to cognitive assessment, diagnosis, and precision treatment, remain unclear. This study aims to identify cognitive impairment brain networks using publicly available large-scale datasets and clinical research, and to explore whether the neuroimaging features of these networks can be utilized for cognitive assessment, diagnosis, and treatment response prediction. First, a "sensitive cognitive assessment model for major psychiatric disorders" will be established through meta-analysis based on sensitive scales. Second, cognitive impairment brain networks will be identified using publicly available large-scale datasets combined with the lesion network mapping method, and their validity will be examined by assessing their non-randomness, reproducibility, symptom specificity, and disease specificity. Third, cognitive assessment and diagnostic models will be developed based on neuroimaging features of these networks. Finally, a combination of cross-sectional and longitudinal study designs will be used in a clinical trial to validate the identified networks and models, and a treatment response prediction model will be established based on the neuroimaging features of cognitive impairment brain networks. This study will advance the understanding of the neurophysiological mechanisms underlying cognitive impairment in major psychiatric disorders, promote the application of neuroimaging in psychiatric diagnosis and treatment, and improve traditional diagnostic, therapeutic, and cognitive assessment approaches.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Second Xiangya Hospital

Changsha, Hunan, 410011, China

Location contact

haohao Yan, Ph.D.

CONTACT

[email protected]

86+073185360921

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 1, For Patients (SZ, BD, MDD):

Diagnosis of schizophrenia (SZ), bipolar disorder (BD), or major depressive disorder (MDD) according to standard diagnostic criteria

First-episode drug-naïve patients or patients who have relapsed after discontinuing medication for more than one month

Aged 18-60 years

Completion of at least 6 years of formal education

2, For Healthy Controls:

Aged 18-60 years

Completion of at least 6 years of formal education

No current or past psychiatric disorders

No first-degree relatives with psychiatric disorders

No history of treatment with psychotropic medications or physical therapy for psychiatric disorders

Exclusion criteria

  • Prior use of psychotropic medications or receipt of physical treatment for psychiatric disorders (for patient group)

Contraindications to MRI scanning

History of brain injury

History of substance abuse

Presence of other neurological disorders

Presence of severe medical or systemic physical illnesses.

Treatment and study plan

Repetitive transcranial magnetic stimulation (rTMS)

Device

Patients will receive repetitive transcranial magnetic stimulation (rTMS) targeting the dorsolateral prefrontal cortex (dlPFC).

Primary outcomes

  1. Cognitive changes

    Time frame: From enrollment to the end of treatment at 8 weeks

    Cognitive Changes Assessed with the MATRICS Consensus Cognitive Battery (MCCB) after Repetitive Transcranial Magnetic Stimulation (rTMS) Intervention

Study contacts

Contact information is provided by the study sponsor or research team.

Wenbin Guo, Ph.D.

CONTACT

[email protected]

+8673185360921

Sponsors and collaborators

Lead sponsor

Central South University

Other

Registry information

Official study title

Study on the Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Application in Cognitive Assessment, Diagnosis, and Precision Treatment

Important dates

Study start
2027
Primary completion
2029
Study completion
2029
First posted
Mar 3, 2026
Registry last updated
Mar 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.